1 Min Read
March 27 (Reuters) - Delcath Systems Inc
* Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.